Savant Capital LLC raised its stake in shares of Allstate Corp. (NYSE:ALL) by 5.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,248 shares of the company’s stock after buying an additional 400 shares during the period. Savant Capital LLC’s holdings in Allstate Corp. were worth $577,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. BlackRock Institutional Trust Company N.A. boosted its stake in Allstate Corp. by 1.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 10,773,067 shares of the company’s stock valued at $725,782,000 after buying an additional 163,623 shares in the last quarter. BlackRock Group LTD boosted its position in shares of Allstate Corp. by 9.1% in the first quarter. BlackRock Group LTD now owns 4,025,435 shares of the company’s stock valued at $271,193,000 after buying an additional 337,002 shares during the period. American Century Companies Inc. boosted its position in shares of Allstate Corp. by 204.5% in the second quarter. American Century Companies Inc. now owns 3,874,045 shares of the company’s stock valued at $270,989,000 after buying an additional 2,601,606 shares during the period. Standard Life Investments LTD boosted its position in shares of Allstate Corp. by 556.2% in the second quarter. Standard Life Investments LTD now owns 3,243,360 shares of the company’s stock valued at $226,857,000 after buying an additional 2,749,105 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Allstate Corp. by 3.4% in the first quarter. JPMorgan Chase & Co. now owns 1,990,307 shares of the company’s stock valued at $134,087,000 after buying an additional 65,427 shares during the period. 76.38% of the stock is owned by institutional investors.
Shares of Allstate Corp. (NYSE:ALL) traded down 0.82% during mid-day trading on Tuesday, reaching $67.84. The company had a trading volume of 3,654,707 shares. The firm’s 50-day moving average price is $68.63 and its 200 day moving average price is $67.86. The company has a market cap of $25.20 billion, a price-to-earnings ratio of 17.08 and a beta of 0.95. Allstate Corp. has a 52-week low of $56.03 and a 52-week high of $70.38.
Allstate Corp. (NYSE:ALL) last released its earnings results on Wednesday, August 3rd. The company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.04. The firm earned $9.16 billion during the quarter, compared to the consensus estimate of $8.14 billion. Allstate Corp. had a return on equity of 9.94% and a net margin of 4.63%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.63 EPS. Equities analysts expect that Allstate Corp. will post $4.39 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, October 3rd. Stockholders of record on Wednesday, August 31st were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Monday, August 29th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.95%. Allstate Corp.’s payout ratio is 33.59%.
Several research analysts recently commented on ALL shares. Zacks Investment Research raised Allstate Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, July 19th. Credit Suisse Group AG set a $73.00 target price on Allstate Corp. and gave the stock a “buy” rating in a research report on Tuesday, August 23rd. Deutsche Bank AG raised their target price on Allstate Corp. from $77.00 to $78.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Barclays PLC reaffirmed an “overweight” rating and issued a $79.00 target price (up from $74.00) on shares of Allstate Corp. in a research report on Friday. Finally, William Blair reaffirmed an “underperform” rating on shares of Allstate Corp. in a research report on Saturday, September 10th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of GBX 72 ($0.94).
In related news, President Matthew E. Winter sold 26,150 shares of the company’s stock in a transaction on Monday, July 11th. The stock was sold at an average price of GBX 70 ($0.91), for a total transaction of £18,305 ($23,893.75). The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Steven E. Shebik sold 41,334 shares of the company’s stock in a transaction on Monday, August 8th. The stock was sold at an average price of GBX 68.86 ($0.90), for a total value of £28,462.59 ($37,152.58). Following the sale, the chief financial officer now owns 102,959 shares of the company’s stock, valued at £70,897.57 ($92,543.49). The disclosure for this sale can be found here. Insiders own 1.58% of the company’s stock.
Allstate Corp. Company Profile
The Allstate Corporation is a holding company for Allstate Insurance Company. The Company and its subsidiaries, including Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries (collectively, Allstate) are engaged in the property-liability insurance and life insurance business.
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allstate Corp. (NYSE:ALL).
Receive News & Ratings for Allstate Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate Corp. and related companies with MarketBeat.com's FREE daily email newsletter.